Immunomedics (IMMU) Reports In-Line Q4 Loss of 13c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
Total costs and expenses: 15.69M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Total costs and expenses: 15.69M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Immunomedics (NASDAQ: IMMU) reported Q4 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $1.13 million.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Morgan Stanley Upgrades CaixaBank SA (CABK:SM) (CAIXY) to Overweight, Top Pick
- JPMorgan Downgrades Laopu Gold (6181:HK) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
